Merck treatment for a type of uterus cancer fails trial
(Reuters) - Merck said on Thursday its treatment for a type of uterus cancer did not meet the main g...
2h ago
Takeda profit slumps by half as Japanese drugmaker rebuilds pipeline
TOKYO (Reuters) - Japan's Takeda Pharmaceutical said full-year earnings slumped by more than half as...
6h ago
UK refuses to sign global vaccine treaty, The Telegraph reports
(Reuters) - Britain is refusing to sign the World Health Organization's pandemic accord because the ...
13h ago
Ascension warns of suspected cyberattack; clinical operations disrupted
(Reuters) - Hospital operator Ascension reported disruptions to its clinical operations on Wednesday...
15h ago
US FDA recommends healthcare providers switch from Getinge's heart devices
(Reuters) - The U.S Food and Drug Administration on Wednesday recommended healthcare facilities tran...
19h ago
Google DeepMind unveils next generation of drug discovery AI model
By Martin Coulter LONDON (Reuters) - Google Deepmind has unveiled the third major version of its &qu...
22h ago
Teva Pharm Q1 profit misses estimates, revenue risea
By Steven Scheer JERUSALEM (Reuters) - Teva Pharmaceutical Industries reported a smaller than expect...
22h ago
Pfizer agrees to settle over 10,000 Zantac lawsuits, Bloomberg News reports
(Reuters) -Pfizer has agreed to settle more than 10,000 lawsuits about cancer risks related to the n...
22h ago
Vitamin Shoppe's telehealth service to provide access to weight-loss drugs
(Reuters) - Health and wellness products retailer Vitamin Shoppe said on Wednesday that subscribers ...
May 08, 2024
Thai PM says cannabis to be re-listed as narcotic by end of 2024
BANGKOK (Reuters) - Thai Prime Minister Srettha Thavisin said on Wednesday that cannabis would be re...
May 08, 2024